87 related articles for article (PubMed ID: 17005169)
1. Immunoassay of serine-phosphorylated isoform of insulin-like growth factor (IGF) binding protein (IGFBP)-1.
Khosravi J; Krishna RG; Bodani U; Diamandi A; Khaja N; Kalra B; Kumar A
Clin Biochem; 2007 Jan; 40(1-2):86-93. PubMed ID: 17005169
[TBL] [Abstract][Full Text] [Related]
2. Human IGFBP-1 is phosphorylated on 3 serine residues: effects of site-directed mutagenesis of the major phosphoserine.
Jones JI; Busby WH; Wright G; Clemmons DR
Growth Regul; 1993 Mar; 3(1):37-40. PubMed ID: 7683525
[TBL] [Abstract][Full Text] [Related]
3. Immunoassay of insulin-like growth factor-binding protein-3 (IGFBP-3): new means to quantifying IGFBP-3 proteolysis.
Diamandi A; Mistry J; Krishna RG; Khosravi J
J Clin Endocrinol Metab; 2000 Jun; 85(6):2327-33. PubMed ID: 10852472
[TBL] [Abstract][Full Text] [Related]
4. Effect of maternal diabetes on phosphorylation of insulin-like growth factor binding protein-1 in cord serum.
Loukovaara M; Leinonen P; Teramo K; Nurminen E; Andersson S; Rutanen EM
Diabet Med; 2005 Apr; 22(4):434-9. PubMed ID: 15787669
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-linked immunosorbent assay of total inhibin: direct determination based on inhibin alpha subunit-specific monoclonal antibodies.
Khosravi J; Krishna RG; Khaja N; Bodani U; Diamandi A
Clin Biochem; 2004 May; 37(5):370-6. PubMed ID: 15087252
[TBL] [Abstract][Full Text] [Related]
6. Site-specific IGFBP-1 hyper-phosphorylation in fetal growth restriction: clinical and functional relevance.
Abu Shehab M; Khosravi J; Han VK; Shilton BH; Gupta MB
J Proteome Res; 2010 Apr; 9(4):1873-81. PubMed ID: 20143870
[TBL] [Abstract][Full Text] [Related]
7. Site specific phosphorylation of insulin-like growth factor binding protein-1 (IGFBP-1) for evaluating clinical relevancy in fetal growth restriction.
Abu Shehab M; Inoue S; Han VK; Gupta MB
J Proteome Res; 2009 Nov; 8(11):5325-35. PubMed ID: 19731965
[TBL] [Abstract][Full Text] [Related]
8. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
9. Generation of anti-insulin-like growth factor-binding protein-related protein 1 (IGFBP-rP1/MAC25) monoclonal antibodies and immunoassay: quantification of IGFBP-rP1 in human serum and distribution in human fluids and tissues.
López-Bermejo A; Khosravi J; Corless CL; Krishna RG; Diamandi A; Bodani U; Kofoed EM; Graham DL; Hwa V; Rosenfeld RG
J Clin Endocrinol Metab; 2003 Jul; 88(7):3401-8. PubMed ID: 12843194
[TBL] [Abstract][Full Text] [Related]
10. Cervical phIGFBP-1 in the evaluation of the risk of preterm delivery.
Paternoster DM; Muresan D; Vitulo A; Serena A; Battagliarin G; Dell'avanzo M; Nicolini U
Acta Obstet Gynecol Scand; 2007; 86(2):151-5. PubMed ID: 17364276
[TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation status in subjects with and without ischaemic heart disease.
Borai A; Livingstone C; Ghayour-Mobarhan M; Abuosa A; Shafi S; Mehta S; Heidari A; Emadzadeh A; Wark G; Ferns G
Atherosclerosis; 2010 Feb; 208(2):593-8. PubMed ID: 19732896
[TBL] [Abstract][Full Text] [Related]
12. The divergent effect of insulin-like growth factor binding protein (IGFBP) - 1 on IGF-induced Steroidogenesis in bovine adrenocortical cells is not due to its phosphorylation status.
Fottner C; Spöttl G; Weber MM
Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):232-9. PubMed ID: 17479439
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
[TBL] [Abstract][Full Text] [Related]
14. Performance characteristics of the IMMULITE 2000 insulin-like growth factor binding protein-3 assay.
Owen WE; Roberts WL
Clin Chim Acta; 2005 Mar; 353(1-2):141-5. PubMed ID: 15698601
[TBL] [Abstract][Full Text] [Related]
15. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
[TBL] [Abstract][Full Text] [Related]
16. The change in the circulating insulin-like growth factor binding protein 1 isoform pattern during the course of oral glucose tolerance test.
Nedić O; Masnikosa R
Metabolism; 2008 May; 57(5):658-61. PubMed ID: 18442629
[TBL] [Abstract][Full Text] [Related]
17. Immunoassay of insulin-like growth factor binding protein-1.
Khosravi MJ; Diamandi A; Mistry J
Clin Chem; 1997 Mar; 43(3):523-32. PubMed ID: 9068598
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting decidual IGFBP-1 levels in the vagina and cervix in the first and mid-second trimester of pregnancy.
Rahkonen L; Unkila-Kallio L; Rutanen EM; Paavonen J
BJOG; 2009 Jan; 116(1):45-54. PubMed ID: 19016684
[TBL] [Abstract][Full Text] [Related]
19. Hormonal regulation of circulating insulin-like growth factor-binding protein-1 phosphorylation status.
Westwood M; Gibson JM; Williams AC; Clayton PE; Hamberg O; Flyvbjerg A; White A
J Clin Endocrinol Metab; 1995 Dec; 80(12):3520-7. PubMed ID: 8530593
[TBL] [Abstract][Full Text] [Related]
20. A specific immunoprecipitation method for isolating isoforms of insulin-like growth factor binding protein-3 from serum.
Bons JA; Michielsen EC; de Boer D; Bouwman FG; Jaeken J; van Dieijen-Visser MP; Rubio-Gozalbo ME; Wodzig WK
Clin Chim Acta; 2008 Jan; 387(1-2):59-65. PubMed ID: 17904539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
